INTENDED FOR UK AND IRELAND HEALTHCARE PROFESSIONALS Patient InformationHomePrescribing information

the CHIESI cf portfolio
LIVING & BREATHING CYSTIC FIBROSIS
  • Quinsair® (levofloxacin) is the
    first inhaled quinolone for the management of chronic pulmonary infections due to Pseudomonas aeruginosa in adult patients with cystic fibrosis.1

    Find out more

  • Bramitob® (tobramycin) is for the management of chronic pulmonary infection due to Pseudomonas aeruginosa in patients with cystic fibrosis aged 6 years and older.2

    Find out more

  • Bronchitol® (mannitol) is for the treatment of cystic fibrosis in adults, as an add-on therapy to best standard of care.3

    Find out more

  • Contact your Chiesi CF Hospital Specialist

    Find out more

  1. Quinsair Summary of Product Characteristics, Chiesi Limited.
  2. Bramitob Summary of Product Characteristics, Chiesi Limited.
  3. Bronchitol Summary of Product Characteristics, Pharmaxis Europe Limited.

IE-CF-2000116  | Oct 2020